Chemours (CC) Misses Q4 EPS by 21c

Chemours (NYSE: CC) reported Q4 EPS of $0.08, $0.21 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.24 billion.

For earnings history and earnings-related data on Chemours (CC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Stifel Starts Victrex Plc. (VCT:LN) (VTXPF) at Buy
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight